FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1058-1060 September 7, 2006 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Montalescot, G. PubMed Citation

About 2.2 million percutaneous coronary interventions (PCIs) were performed worldwide in 2004 (Mead D: personal communication). Success rates of more than 97%, mortality rates of less than 0.5%, and rates of emergency bypass surgery of less than 0.5% can be anticipated with elective procedures. Major obstacles initially confronting the field — including the inability to reach complex or tortuous lesions, to cross lesions, and to dilate lesions, as well as bifurcation disease, occlusive dissection, and abrupt closure — have largely been overcome. Restenosis has been markedly reduced with the advent of drug-eluting stents.¹

As the technical obstacles to safe, effective, . . . [Full Text of this Article]

Source Information

From the University of Miami School of Medicine, Miami.

This article has been cited by other articles:

• Jolic{oelig}ur, E. M., O'Neill, W. W., Hellkamp, A., Hamm, C. W., Holmes, D. R. Jr., Al-Khalidi, H. R., Patel, M. R., Van de Werf, F. J., Pieper, K., Armstrong, P. W., Granger, C. B., for the APEX-AMI Investigators, (2009). Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J 30: 2575-2583 [Abstract] [Full Text]  
• Stabile, E., Nammas, W., Salemme, L., Sorropago, G., Cioppa, A., Tesorio, T., Ambrosini, V., Campopiano, E., Popusoi, G., Biondi Zoccai, G., Rubino, P. (2008). The CIAO (Coronary Interventions Antiplatelet-based Only) Study: A Randomized Study Comparing Standard Anticoagulation Regimen to Absence of Anticoagulation for Elective Percutaneous Coronary Intervention. J Am Coll Cardiol 52: 1293-1298 [Abstract] [Full Text]  
• Chase, A J, Fretz, E B, Warburton, W P, Klinke, W P, Carere, R G, Pi, D, Berry, B, Hilton, J D (2008). Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 94: 1019-1025 [Abstract] [Full Text]  
• Dixon, S. R., Grines, C. L., O'Neill, W. W. (2007). The Year in Interventional Cardiology. J Am Coll Cardiol 50: 270-285 [Full Text]  
• Bhala, N., Hamon, M., Riddell, J. W., Karthikeyan, G., Pasceri, V., Schuler, J., Altenberger, J., Heigert, M., Montalescot, G., White, H. D., Steinhubl, S. R. (2006). Enoxaparin in elective percutaneous coronary intervention.. NEJM 355: 2788-2789 [Full Text]  
• (2006). Which Type of Heparin for Elective PCI?. Journal Watch Cardiology 2006: 4-4 [Full Text]